Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05267899 |
| Title | A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Zhejiang Haichang Biotech Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Valkyrie Clinical Trials | RECRUITING | Los Angeles | California | 90067 | United States | Details |
| The Oncology Institute of Hope and Innovation | RECRUITING | Whittier | California | 90603 | United States | Details |
| University of Maryland, Greenebaum Comprehensive Cancer Center | RECRUITING | Baltimore | Maryland | 21201 | United States | Details |